CNS Pharmaceuticals, Inc. short interest in 2025
In 2025, CNS Pharmaceuticals, Inc.'s disclosed short interest ran from 11.50% of shares outstanding on 31 Mar 2025 to 4.52% on 31 Dec 2025, a change of -6.98 percentage points. The year's high was 24.85% on 15 May 2025 and its low 2.80% on 28 Nov 2025, averaging 10.66% across 16 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 4.43 days on 30 Apr 2025. Full history: CNS Pharmaceuticals, Inc..
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 11.50% (31 Mar 2025)
- End of year
- 4.52% (31 Dec 2025)
- Change
- -6.98 pp
- High
- 24.85% (15 May 2025)
- Low
- 2.80% (28 Nov 2025)
- Average
- 10.66%
- Highest days to cover
- 4.43 (30 Apr 2025)
- SEC filings marked
- 4
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 31 Mar 2025 | 11.50% | 1.00 | 10-K filed |
| 15 Apr 2025 | 11.00% | 1.27 | |
| 30 Apr 2025 | 21.39% | 4.43 | |
| 15 May 2025 | 24.85% | 1.00 | 10-Q filed |
| 13 Jun 2025 | 15.66% | 1.66 | |
| 30 Jun 2025 | 13.56% | 2.23 | |
| 15 Jul 2025 | 12.73% | 2.59 | |
| 15 Aug 2025 | 6.70% | 1.21 | 10-Q filed |
| 29 Aug 2025 | 11.06% | 1.00 | |
| 15 Sep 2025 | 9.37% | 2.03 | |
| 30 Sep 2025 | 7.27% | 1.00 | |
| 15 Oct 2025 | 7.96% | 1.33 | |
| 14 Nov 2025 | 5.98% | 1.77 | 10-Q filed |
| 28 Nov 2025 | 2.80% | 2.60 | |
| 15 Dec 2025 | 4.13% | 1.91 | |
| 31 Dec 2025 | 4.52% | 1.08 |
See also: CNS Pharmaceuticals, Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.